PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Sharifi, Mohsen
TI  - Moderate PE Treated with Thrombolysis (MOPETT Study)
DP  - 2012 Jun 01
TA  - MD Conference Express
PG  - 13--14
VI  - 12
IP  - 4
4099  - http://mdc.sagepub.com/content/12/4/13.2.short
4100  - http://mdc.sagepub.com/content/12/4/13.2.full
AB  - Pulmonary embolism (PE) is one of the most common preventable causes of death (responsible for >100,000 deaths annually) and the third leading cause of cardiovascular mortality. New data from the Moderate Pulmonary Embolism Treated with Thrombolysis [MOPETT] study suggest that moderate PE patients may be managed with reduced-dose issue plasminogen activator and modified anticoagulation.